SMTL ID : 4bkt.2 (3 other biounits)

von Hippel Lindau protein:ElonginB:ElonginC complex, in complex with (2S,4R)-N-methyl-1-[2-(3-methyl-1,2-oxazol-5-yl)ethanoyl]-4-oxidanyl-pyrrolidine-2-carboxamide

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.35 Å

Oligo State

hetero-oligomer

Ligands

1 x ARG: ARGININE(Covalent)

ARG.1: 4 residues within 4Å: Chain C: L.150, T.151, Q.152, E.153 1 PLIP interactions: 1 interactions with chain C Hydrogen bonds: C:L.150

1 x QD0: (2S,4R)-N-methyl-1-[2-(3-methyl-1,2-oxazol-5-yl)ethanoyl]-4-oxidanyl-pyrrolidine-2-carboxamide(Non-covalent)

QD0.2: 8 residues within 4Å: Chain C: W.37, F.40, Y.47, H.59, S.60, Y.61, H.64, W.66 6 PLIP interactions: 6 interactions with chain C Hydrophobic interactions: C:W.66 Hydrogen bonds: C:H.59, C:S.60, C:Y.61, C:H.64 pi-Stacking: C:Y.61

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Dias, D.M. et al., Is NMR Fragment Screening Fine-Tuned to Assess Druggability of Protein-Protein Interactions?. Acs Med.Chem.Lett. (2014)

Release Date

2013-11-27

Peptides

TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2: A
TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1: B
VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
G

B
H

C
I

TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2

TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1

VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR

Related Entries With Identical Sequence